Reteplase description: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Protected "Reteplase description": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Reteplase#Structure]]
{{Reteplase}}
{{CMG}}; {{AE}} {{AZ}}


==Description==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
Retavase® (Reteplase) is a non-glycosylated deletion mutein of tissue [[plasminogen activator]] (tPA), containing the kringle 2 and the protease domains of human tPA. Retavase® contains 355 of the 527 amino acids of native tPA (amino acids 1-3 and 176-527). Retavase® is produced by recombinant DNA technology in[[ E. coli]]. The protein is isolated as inactive inclusion bodies from [[E. coli]], converted into its active form by an in vitro folding process and purified by chromatographic separation. The molecular weight of Reteplase is 39,571 daltons.
[[Category: Anticoagulants]]
 
Potency is expressed in units (U) using a reference standard which is specific for Retavase® and is not comparable with units used for other thrombolytic agents.
 
Retavase® is a sterile, white, lyophilized powder for intravenous bolus injection after reconstitution with Sterile Water for Injection, USP (without preservatives). Following reconstitution, the pH is 6.0 ± 0.3. Retavase® is supplied as a 10.4 unit vial to ensure sufficient drug for administration of each 10 unit injection. Each single-use vial contains<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RETAVASE (RETEPLASE) KIT [EKR THERAPEUTICS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ae6656-977c-4105-8528-bee664aab27a | publisher =  | date =  | accessdate =  }}</ref>:
 
:*Reteplase : 18.1 mg
 
:*Tranexamic Acid : 8.32 mg
 
:*Dipotassium Hydrogen Phosphate : 136.24 mg
 
:*Phosphoric Acid : 51.27 mg
 
:*Sucrose : 364.0 mg
 
:*Polysorbate 80 : 5.20 mg
 
==References==
{{Reflist}}
 
{{FDA}}
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 17:04, 20 August 2015